Skip to main content
. 2020 Apr 1;13:2725–2738. doi: 10.2147/OTT.S236359

Figure 2.

Figure 2

The expression of FSTL3 was related to the survival rate of NSCLC patients. (A) High FSTL3 levels reduced overall survival rate in LUAD patients. (B) High FSTL3 levels reduced overall survival rate in LUSC patients. (C) High FSTL3 levels reduced disease-free survival rate in LUAD patients. (D) High FSTL3 levels reduced disease-free survival rate in LUSC patients.

Abbreviations: LUAD, lung adenocarcinoma; LUSC, lung squamous carcinoma.